Amlodipine Besylate Tablet
Product Images NDC 69097-127

6 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69097-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of amlodipine besylate, illustrating the molecular composition and arrangement of atoms in the active ingredient. The diagram shows the presence of chlorine, oxygen, nitrogen, sulfur, and carbon atoms forming the distinctive ring and side groups characteristic of amlodipine besylate.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A Kaplan-Meier survival curve comparing event rates over 24 months between Amlodipine and Placebo groups. The x-axis shows time in months, and the y-axis shows event rate. The curve indicates lower event rates for Amlodipine compared to placebo, with a reported p-value of 0.003, hazard ratio of 0.691, and 95% confidence interval ranging from 0.54 to 0.88.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A forest plot displaying hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine Besylate and placebo. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease, presence of vessel stenosis, and PCI-stent strata. The x-axis represents hazard ratio ranging from 0.0 to 2.0, with data points positioned to favor either Amlodipine or placebo.*
FDA Label Image

Container-label-2pt5mg-90s (Container Label 2pt5mg 90s)

Container-label-2pt5mg-90s (Container Label 2pt5mg 90s)
Label for Amlodipine Besylate Tablets, USP 2.5 mg by Cipla USA Inc. The label states prescription use, contains 90 tablets, and includes storage instructions and manufacturer information. The dosage strength 2.5 mg is prominently displayed in a blue box on the left side.*
FDA Label Image

Container-label-5mg-90s (Container Label 5mg 90s)

Container-label-5mg-90s (Container Label 5mg 90s)
A rectangular label for Amlodipine Besylate Tablets USP 5 mg by Cipla USA Inc. It shows the drug name, strength 5 mg, quantity of 90 tablets, and storage instructions. The label notes it is Rx only and includes directions to dispense with a patient leaflet. Manufacturer details and a barcode are also visible.*
FDA Label Image

Container-label-10mg-90s (Container Label 10mg 90s)

Container-label-10mg-90s (Container Label 10mg 90s)
Label for Amlodipine Besylate Tablets USP, 10 mg strength, oral tablets. The label indicates a package of 90 tablets and is marked for prescription use only. It includes manufacturer information for Cipla USA Inc., dispensing instructions, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.